ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
Documented follow-up to memory concerns reported at the Medicare Annual Wellness Visit.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionThe Medicare Annual Wellness Visit (AWV) may improve timely detection of Alzheimer's disease and related dementias (ADRD), yet little is known about the frequency of follow-up on patient-reported memory concerns during the AWV.
methodsWe use electronic medical record (EMR) data from an academic health system to examine EMR-documented follow-up actions for patients with newly reported memory concerns on the AWV health risk assessment, including formal cognitive assessment or specialist referrals.
resultsThe 1411 patients with newly reported memory concerns were predominantly white (70%) and female (63%), with an average age of 78 (SD 7.5). At the AWV, few patients received a cognitive assessment (5.4%; n = 76), specialist referral (2.1%; n = 30), or both (0.4%; n = 6). In adjusted analyses, we did not observe statistically significant differences by sociodemographic characteristics. DISCUSSION: This EMR-based study highlights an opportunity to better leverage the AWV to improve ADRD detection and care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.